NDC Trademark

Trademark Overview


On Tuesday, April 28, 2015, a trademark application was filed for NDC with the United States Patent and Trademark Office. The USPTO has given the NDC trademark a serial number of 86613157. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, July 1, 2019. This trademark is owned by Memorial Sloan Kettering Cancer Center. The NDC trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Pharmaceutical preparations and substances for diagnosis and targeted treatment of cancer and tumor diseases; pharmaceutical preparations and substances for diagnosis and treatment of viral, bacterial, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, inflammatory, dermatological, psychiatric and immune system related diseases and disorders; therapeutic agents for diagnosis and targeted treatment of cancer and tumor diseases; therapeutic agents for diagnosis and treatment of viral, bacterial, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, inflammatory, dermatological, psychiatric and immune system related diseases and disorders; therapeutic pharmaceuticals and substances for the diagnosis and treatment of viral, bacterial, ...

Research and development in the fields of pharmaceuticals, biotechnology, therapeutics, and drug formulation and delivery; research and development in the field of targeted therapies for cancer and tumor diseases; research and development in the field of targeted therapies for viral, bacterial, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, inflammatory, dermatological, psychiatric and immune system related diseases and disorders; consulting services in the field of scientific research; consulting services in the field of research and development for pharmaceuticals, biotechnology, therapeutics, and drug formulation and delivery; consulting services in the field of clinical trials; testing, inspection, research, or development of pharmaceutical and therapeutic preparations; pharmaceutical and therapeutic drug development services; pharmaceutical and the...
ndc

General Information


Serial Number86613157
Word MarkNDC
Filing DateTuesday, April 28, 2015
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, July 1, 2019
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 5, 2016

Trademark Statements


Goods and ServicesPharmaceutical preparations and substances for diagnosis and targeted treatment of cancer and tumor diseases; pharmaceutical preparations and substances for diagnosis and treatment of viral, bacterial, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, inflammatory, dermatological, psychiatric and immune system related diseases and disorders; therapeutic agents for diagnosis and targeted treatment of cancer and tumor diseases; therapeutic agents for diagnosis and treatment of viral, bacterial, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, inflammatory, dermatological, psychiatric and immune system related diseases and disorders; therapeutic pharmaceuticals and substances for the diagnosis and treatment of viral, bacterial, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, inflammatory, dermatological, psychiatric and immune system related diseases and disorders; pharmaceutical preparations and substances for diagnosis and treatment of diseases and disorders; therapeutic agents for diagnosis and treatment of diseases and disorders
Goods and ServicesResearch and development in the fields of pharmaceuticals, biotechnology, therapeutics, and drug formulation and delivery; research and development in the field of targeted therapies for cancer and tumor diseases; research and development in the field of targeted therapies for viral, bacterial, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, inflammatory, dermatological, psychiatric and immune system related diseases and disorders; consulting services in the field of scientific research; consulting services in the field of research and development for pharmaceuticals, biotechnology, therapeutics, and drug formulation and delivery; consulting services in the field of clinical trials; testing, inspection, research, or development of pharmaceutical and therapeutic preparations; pharmaceutical and therapeutic drug development services; pharmaceutical and therapeutic product evaluation; conducting early evaluations in the field of new pharmaceuticals and therapeutics; conducting quality control testing, feasibility testing, toxicology testing and pharmacology testing for pharmaceuticals and therapeutics; laboratory research services relating to pharmaceuticals and therapeutics; medical and scientific research, namely, conducting clinical trials for others; product safety testing for pharmaceuticals and therapeutics

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSaturday, May 9, 2015
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, February 25, 2016
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameMemorial Sloan Kettering Cancer Center
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressNew York, NY 10065

Party NameMemorial Sloan Kettering Cancer Center
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressNew York, NY 10065

Trademark Events


Event DateEvent Description
Monday, July 1, 2019ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, July 1, 2019ABANDONMENT - NO USE STATEMENT FILED
Friday, November 30, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, November 29, 2018EXTENSION 5 GRANTED
Monday, November 19, 2018EXTENSION 5 FILED
Thursday, November 29, 2018CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, November 19, 2018TEAS EXTENSION RECEIVED
Tuesday, May 15, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, May 11, 2018EXTENSION 4 GRANTED
Friday, May 11, 2018EXTENSION 4 FILED
Friday, May 11, 2018TEAS EXTENSION RECEIVED
Friday, October 27, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, October 25, 2017EXTENSION 3 GRANTED
Wednesday, October 25, 2017EXTENSION 3 FILED
Wednesday, October 25, 2017TEAS EXTENSION RECEIVED
Friday, May 12, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, May 10, 2017EXTENSION 2 GRANTED
Wednesday, May 10, 2017EXTENSION 2 FILED
Wednesday, May 10, 2017TEAS EXTENSION RECEIVED
Tuesday, November 8, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, November 4, 2016EXTENSION 1 GRANTED
Friday, November 4, 2016EXTENSION 1 FILED
Friday, November 4, 2016TEAS EXTENSION RECEIVED
Tuesday, May 31, 2016NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, April 5, 2016OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 5, 2016PUBLISHED FOR OPPOSITION
Wednesday, March 16, 2016NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, March 2, 2016LAW OFFICE PUBLICATION REVIEW COMPLETED
Thursday, February 25, 2016APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, February 25, 2016TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, February 25, 2016CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, February 18, 2016ASSIGNED TO LIE
Thursday, February 11, 2016TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, August 12, 2015NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, August 12, 2015NON-FINAL ACTION E-MAILED
Wednesday, August 12, 2015NON-FINAL ACTION WRITTEN
Thursday, August 6, 2015ASSIGNED TO EXAMINER
Saturday, May 9, 2015NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Friday, May 1, 2015NEW APPLICATION ENTERED IN TRAM